The molecular characterization and clinical management of multiple myeloma in the post-genome era

Keyphrases

• Clinical Management 100%
• Multiple Myeloma 100%
• Gene Expression Profiling 100%
• Postgenomics 100%
• Molecular Characterization 100%
• Expression Pattern 33%
• High-risk Features 16%
• Poor Outcome 16%
• Cancer Biology 16%
• High Risk 16%
• Therapeutic Regimen 16%
• Cell Differentiation 16%
• Clinical Outcomes 16%
• Risk Stratification 16%
• Gene Expression 16%
• Microarray 16%
• Molecular Techniques 16%
• Drug Resistance 16%
• Clinical Behavior 16%
• Disease Risk 16%
• Clinical Features 16%
• Poor Clinical Outcomes 16%
• Common Mechanisms 16%
• Mechanistic Insight 16%
• Drug Sensitivity 16%
• Cell Growth 16%
• Tumor Samples 16%
• Serial Sampling 16%
• Risk Increase 16%
• Disease Mechanisms 16%
• Therapy-resistant 16%
• Individual Agent 16%
• Hyperdiploid 16%
• Disease Evolution 16%
• Relapsed Disease 16%
• Resistant Cells 16%
• Newly Diagnosed multiple Myeloma 16%
• Ploidy Change 16%
• Class-specific 16%
• Molecular Classes 16%
• Disease Class 16%
• Recurrent Chromosomal Translocations 16%

Medicine and Dentistry

• Clinical Management 100%
• Gene Expression Profiling 100%
• Multiple Myeloma 100%
• Diseases 50%
• Malignant Neoplasm 16%
• Neoplasm 16%
• Cell Differentiation 16%
• Drug Sensitivity 16%
• Disease Course 16%
• Drug Resistance 16%
• Gene Expression 16%
• Clinical Feature 16%
• Cell Growth 16%
• Chromosome Translocation 16%
• Ploidy 16%
• Cancer Pathobiology 16%

Biochemistry, Genetics and Molecular Biology

• Gene Expression Profiling 100%
• Genomics 33%
• Cellular Differentiation 16%
• Drug Resistance 16%
• Gene Expression 16%
• Drug Sensitivity 16%
• Cell Growth 16%
• Chromosomal Translocation 16%
• Ploidy 16%